Restless Legs Syndrome
JAMA Clinical Reviews
00:00
Dopamine agonists and augmentation risk
Winkelman defines augmentation, its features, and the ~8% per year incidence with dopamine agonists.
Play episode from 15:40
Transcript
Winkelman defines augmentation, its features, and the ~8% per year incidence with dopamine agonists.